Advanced Clinical Laboratories, INC.

Advanced Clinical Laboratories, INC. was paid $1.81M by Medicaid between Jan 2018 and Dec 2024, across 141 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 40% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#30 of 225

Median peer was paid$74K

This provider vs. median25×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	274,030	$7K
2019	294,513	$108K
2020	478,611	$398K
2021	418,271	$574K
2022	299,624	$224K
2023	469,899	$403K
2024incomplete	320,608	$97K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	40%	88,135	26,039	$732K
80053	Comprehensive metabolic panel	8.0%	178,857	95,407	$146K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	4.3%	10,650	2,475	$78K
80048	Basic metabolic panel (calcium, ionized)	3.8%	112,259	55,288	$69K
82607		2.9%	23,840	16,236	$53K
84443	Thyroid stimulating hormone (TSH)	2.7%	56,722	37,836	$50K
88305	Level IV - Surgical pathology, gross and microscopic examination	2.7%	9,352	6,731	$50K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.5%	261,924	128,739	$45K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	2.4%	454,196	177,124	$44K
82652		2.3%	12,667	8,213	$41K
87186		2.3%	48,282	29,564	$41K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.8%	22,455	15,514	$32K

129 more codes

U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.7%	35,107	$30K
80061	Lipid panel	1.6%	44,727	$29K
83036	Hemoglobin; glycosylated (A1C)	1.5%	67,998	$28K
88112		1.5%	13,246	$27K
83880		1.3%	12,482	$24K
87086	Culture, bacterial; quantitative colony count, urine	1.2%	80,609	$23K
80164		1.1%	20,344	$19K
82140		<1%	19,572	$18K
83735		<1%	18,768	$14K
87077		<1%	59,094	$12K
80177		<1%	13,587	$11K
88312		<1%	4,493	$11K
83970		<1%	3,478	$10K
80202		<1%	6,094	$9K
85610		<1%	58,441	$9K
82746		<1%	18,369	$8K
84153		<1%	3,032	$8K
81001		<1%	64,912	$8K
87631		<1%	1,380	$8K
87506		<1%	1,847	$7K
84134		<1%	5,747	$7K
84481		<1%	3,143	$6K
82728		<1%	9,976	$5K
86403		<1%	5,251	$5K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	361,303	$5K
87088		<1%	49,482	$4K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	2,053	$4K
86141		<1%	4,030	$4K
87070		<1%	8,291	$4K
84439		<1%	10,049	$4K
80074		<1%	496	$4K
86140		<1%	4,822	$4K
84436		<1%	6,982	$4K
36415	Collection of venous blood by venipuncture	<1%	70,996	$3K
83721		<1%	4,456	$3K
85027		<1%	11,879	$3K
83550		<1%	11,156	$3K
85014		<1%	9,312	$3K
80076		<1%	7,882	$2K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	431	$2K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	20,585	$2K
80185		<1%	4,421	$2K
84480		<1%	2,850	$2K
83540		<1%	12,728	$2K
82274		<1%	4,028	$2K
80162		<1%	3,631	$2K
87481		<1%	1,718	$2K
82977		<1%	1,359	$2K
87040		<1%	1,694	$1K
85651		<1%	8,562	$1K
82565		<1%	2,531	$1K
80069		<1%	1,604	$996.43
84550		<1%	5,446	$874.78
87390		<1%	148	$840.43
87106		<1%	1,010	$815.82
82570		<1%	2,138	$758.62
87205		<1%	8,058	$693.72
80184		<1%	1,060	$649.02
84145		<1%	857	$609.65
84403		<1%	97	$608.47
85044		<1%	4,293	$593.88
86702		<1%	207	$582.96
84100		<1%	4,817	$566.65
86038		<1%	236	$559.14
82550		<1%	1,324	$557.55
87653		<1%	1,706	$547.18
87493		<1%	4,187	$545.10
87641		<1%	1,724	$528.94
86376		<1%	146	$519.59
82248		<1%	3,151	$508.23
85379		<1%	1,258	$445.84
86701		<1%	209	$429.71
84132		<1%	2,133	$422.89
85730		<1%	1,742	$410.69
83690		<1%	357	$394.02
84479		<1%	1,430	$354.58
80156		<1%	487	$337.37
82040		<1%	1,448	$311.35
87324		<1%	897	$310.75
82043		<1%	1,462	$304.36
84402		<1%	31	$290.13
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	43	$277.12
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	43	$274.12
86803		<1%	113	$270.71
85018		<1%	9,284	$268.91
86706		<1%	105	$264.35
80178		<1%	643	$252.84
84154		<1%	485	$233.76
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	404	$213.50
86780		<1%	113	$207.87
87640		<1%	1,361	$206.23
87340		<1%	73	$175.70
87500		<1%	1,263	$174.00
86431		<1%	140	$152.61
84484		<1%	26	$115.12
87505		<1%	15	$92.65
80050	General health panel	<1%	154	$81.87
86709		<1%	33	$73.39
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	606	$70.38
83615		<1%	786	$70.11
87507		<1%	18	$62.74
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	652	$60.49
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	20	$60.18
86705		<1%	15	$54.93
86334		<1%	24	$36.61
82784		<1%	74	$31.54
83001		<1%	21	$25.34
84520		<1%	268	$25.15
84156		<1%	309	$12.16
84155		<1%	41	$5.48
82150		<1%	24	$4.39
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	0%	5,336	$0.00
88304		0%	113	$0.00
83090		0%	22	$0.00
82435		0%	23	$0.00
80170		0%	29	$0.00
84144		0%	21	$0.00
83605		0%	59	$0.00
83002		0%	21	$0.00
82670		0%	21	$0.00
82947		0%	115	$0.00
82247		0%	13	$0.00
84165		0%	21	$0.00
82374		0%	23	$0.00
99499		0%	74	$0.00
82310		0%	31	$0.00
82627		0%	21	$0.00
83698		0%	13	$0.00
84466		0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTILTON, VICKI (COO)